SpectraCure
0.17 SEK
-2.91 %
Less than 1K followers
SPEC
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-2.91 %
-14.45 %
-0.95 %
-61.16 %
-84.57 %
-67.76 %
-94.37 %
-97.83 %
-73.24 %
SpectraCure operates in the medical technology sector. The company specializes in research and development of medical technology systems used for the treatment of prostate cancer. The cancer treatments are based on proprietary systems that emit laser light sources and photoreactive drugs, a treatment methodology used for internal solid tumors of various types. The largest operations are found in the Nordic market. The company has its headquarters in Lund.
Read moreMarket cap
68.41M SEK
Turnover
76.44K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
19/2
2026
Annual report '25
27/5
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
Fortsatt lovande resultat i SpectraCures studie för primär lokaliserad prostatacancer
SpectraCure redovisar goda resultat avseende PSA-värden i klinisk studie för återfall av prostatacancer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools